French Microdosing Startup Mabel Raises €600K to Launch Psychedelic-Based Women’s Health Platform
Summary
Mabel, a Paris-based women’s health startup, launched after two years of R&D and raised €600K in pre-seed funding. The company sells a five-week mindful microdosing program that combines psilocybin truffles, mushroom-based supplements, and access to the Mabel app. The app includes classes, exercises, journal tools, and intention guides aimed at mental well-being. Mabel also offers non-psychedelic mushroom products and positions its platform as a new approach to women’s mental health.
Funding
Amount
$648.0K
Total raised
Date
November 8, 2024
Announcement date
Investors
Partech
Lead investors
Company
mabel.life
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected